AnTolRx
Latest round
- Series A
Last raised
- Sep 2016
Total raised
- $4M
Investors
- 3
About AnTolRx
Founded in 2015 and based in Cambridge, Massachusetts, AnTolRx, Inc. develops proprietary pharmaceuticals, that target pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype in order to treat diseases.
Who invested in AnTolRx
3 investors across 1 round
See all investors in AnTolRx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 8, 2016
Amount
$4M
Investors
Questions about AnTolRx
Who invested in AnTolRx?
AnTolRx has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AnTolRx raised?
AnTolRx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AnTolRx last raise money?
AnTolRx's most recent round on record is a Series A, in Sep 2016.
What does AnTolRx do?
Founded in 2015 and based in Cambridge, Massachusetts, AnTolRx, Inc.
Where is AnTolRx headquartered?
AnTolRx is headquartered in Cambridge, US.
Which VCs invest in companies like AnTolRx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at AnTolRx's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like AnTolRx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.